Rocket Pharmaceuticals, Inc. SEC filings RCKT

Rocket Pharmaceuticals, Inc. has 968 filings in SEC EDGAR's recent list, going back to Feb 25, 2004. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (material agreement, new debt, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.

Rocket Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
144 Notice of proposed sale Nov 5, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 30, 2026 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Oct 6, 2026 Sep 30, 2026
4 Insider transaction Sep 15, 2026 Sep 11, 2026
144 Notice of proposed sale Sep 15, 2026 —
8-K Current report
Regulation FD disclosure
Sep 15, 2026 Sep 15, 2026
144 Notice of proposed sale Sep 14, 2026 —
144 Notice of proposed sale Sep 11, 2026 —
144 Notice of proposed sale Sep 11, 2026 —
25-NSE Delisting notice Sep 2, 2026 —
8-K Current report
Officer or director change
Aug 27, 2026 Aug 21, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
144 Notice of proposed sale Aug 18, 2026 —
144 Notice of proposed sale Aug 18, 2026 —
144 Notice of proposed sale Aug 18, 2026 —
4 Insider transaction Aug 17, 2026 Aug 13, 2026
4 Insider transaction Aug 17, 2026 Aug 13, 2026
4 Insider transaction Aug 13, 2026 Aug 11, 2026
4 Insider transaction Aug 13, 2026 Aug 11, 2026
144 Notice of proposed sale Aug 13, 2026 —
144 Notice of proposed sale Aug 13, 2026 —
144 Notice of proposed sale Aug 11, 2026 —
144 Notice of proposed sale Aug 11, 2026 —
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
8-K Current report
Regulation FD disclosure
Aug 3, 2026 Aug 3, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 31, 2026 —
S-8 Employee stock plan registration Jul 14, 2026 —
3 Initial insider ownership Jul 8, 2026 Jul 8, 2026
144 Notice of proposed sale Jul 7, 2026 —
4 Insider transaction Jul 6, 2026 Jun 18, 2026
4 Insider transaction Jul 6, 2026 Jun 18, 2026
4 Insider transaction Jul 6, 2026 Jun 18, 2026
4 Insider transaction Jul 6, 2026 Jun 18, 2026
4 Insider transaction Jul 6, 2026 Jun 18, 2026
4 Insider transaction Jul 6, 2026 Jun 18, 2026
8-K Current report
Officer or director change
Jun 30, 2026 Jun 24, 2026
8-K Current report
Acquisition or sale of assets, Regulation FD disclosure
Jun 12, 2026 Jun 10, 2026
SC TO-I/A Filing May 28, 2026 —
4 Insider transaction May 28, 2026 May 26, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
144 Notice of proposed sale May 21, 2026 —
8-K Current report
Shareholder vote results
May 21, 2026 May 20, 2026
144 Notice of proposed sale May 19, 2026 —
144 Notice of proposed sale May 19, 2026 —
144 Notice of proposed sale May 19, 2026 —
4 Insider transaction May 14, 2026 May 13, 2026
4 Insider transaction May 14, 2026 May 13, 2026
4 Insider transaction May 14, 2026 May 13, 2026
144 Notice of proposed sale May 13, 2026 —
144 Notice of proposed sale May 13, 2026 —
144 Notice of proposed sale May 13, 2026 —
4 Insider transaction May 11, 2026 May 7, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
144 Notice of proposed sale May 7, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Apr 28, 2026 Apr 26, 2026
SC TO-I Filing Apr 27, 2026 —
ARS Annual report to shareholders Apr 6, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 6, 2026 —
DEF 14A Proxy statement Apr 6, 2026 May 20, 2026
SC TO-C Filing Apr 3, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
8-K Current report
Regulation FD disclosure
Mar 27, 2026 Mar 26, 2026
PRE 14A Preliminary proxy statement Mar 25, 2026 May 20, 2026
EFFECT Filing Mar 10, 2026 —
8-K Current report
Material agreement, Agreement ended
Mar 10, 2026 Mar 10, 2026
424B5 Prospectus supplement Mar 10, 2026 —
CORRESP Letter to the SEC Mar 6, 2026 —
UPLOAD Letter from the SEC Mar 6, 2026 —
S-3 Shelf registration Mar 2, 2026 —
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
4 Insider transaction Feb 13, 2026 Feb 11, 2026
4 Insider transaction Feb 13, 2026 Feb 11, 2026
4 Insider transaction Feb 13, 2026 Feb 11, 2026
4 Insider transaction Feb 13, 2026 Feb 11, 2026
4 Insider transaction Feb 13, 2026 Feb 11, 2026
4 Insider transaction Feb 13, 2026 Feb 11, 2026
144 Notice of proposed sale Feb 13, 2026 —
144 Notice of proposed sale Feb 13, 2026 —
144 Notice of proposed sale Feb 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 30, 2026 —
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Nov 20, 2025 Nov 18, 2025
4 Insider transaction Nov 20, 2025 Nov 18, 2025
4 Insider transaction Nov 20, 2025 Nov 18, 2025
4 Insider transaction Nov 20, 2025 Nov 18, 2025
144 Notice of proposed sale Nov 18, 2025 —
144 Notice of proposed sale Nov 18, 2025 —
144 Notice of proposed sale Nov 18, 2025 —
144 Notice of proposed sale Nov 18, 2025 —
4 Insider transaction Nov 10, 2025 Nov 3, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
4 Insider transaction Oct 16, 2025 Oct 14, 2025
144 Notice of proposed sale Oct 14, 2025 —
8-K Current report
Other events
Oct 14, 2025 Oct 14, 2025
4 Insider transaction Oct 8, 2025 Oct 6, 2025
4 Insider transaction Oct 3, 2025 Sep 24, 2025
3 Initial insider ownership Oct 3, 2025 Sep 24, 2025
8-K Current report
Officer or director change
Oct 3, 2025 Sep 29, 2025
8-K Current report
Other events
Oct 3, 2025 Oct 3, 2025
8-K Current report
Officer or director change
Sep 29, 2025 Sep 23, 2025
4 Insider transaction Sep 23, 2025 Sep 19, 2025
3 Initial insider ownership Sep 22, 2025 Sep 15, 2025
8-K Current report
Material agreement
Sep 17, 2025 Sep 11, 2025
4 Insider transaction Sep 9, 2025 Sep 8, 2025
4 Insider transaction Sep 9, 2025 Sep 8, 2025
4 Insider transaction Sep 9, 2025 Sep 8, 2025
4 Insider transaction Aug 27, 2025 Aug 27, 2025
8-K Current report
Officer or director change
Aug 25, 2025 Aug 20, 2025
4 Insider transaction Aug 20, 2025 Aug 18, 2025
4 Insider transaction Aug 20, 2025 Aug 18, 2025
4 Insider transaction Aug 20, 2025 Aug 18, 2025
4 Insider transaction Aug 20, 2025 Aug 18, 2025
8-K Current report
Other events
Aug 20, 2025 Aug 20, 2025
144 Notice of proposed sale Aug 19, 2025 —
144 Notice of proposed sale Aug 19, 2025 —
144 Notice of proposed sale Aug 19, 2025 —
4 Insider transaction Aug 18, 2025 Aug 14, 2025
4 Insider transaction Aug 18, 2025 Aug 14, 2025
4 Insider transaction Aug 18, 2025 Aug 14, 2025
144 Notice of proposed sale Aug 18, 2025 —
144 Notice of proposed sale Aug 18, 2025 —
144 Notice of proposed sale Aug 18, 2025 —
144 Notice of proposed sale Aug 14, 2025 —
144 Notice of proposed sale Aug 14, 2025 —
144 Notice of proposed sale Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations, Officer or director change
Aug 7, 2025 Aug 4, 2025
4 Insider transaction Aug 6, 2025 Aug 4, 2025
3 Initial insider ownership Aug 4, 2025 Jul 7, 2025
8-K Current report
Other events
Jul 24, 2025 Jul 24, 2025
8-K Current report
Exit or restructuring costs
Jul 23, 2025 Jul 23, 2025
4 Insider transaction Jul 18, 2025 Jun 18, 2025
4 Insider transaction Jul 18, 2025 Jun 18, 2025
4 Insider transaction Jul 18, 2025 Jun 18, 2025
4 Insider transaction Jul 18, 2025 Jun 18, 2025
4 Insider transaction Jul 18, 2025 Jun 18, 2025
4 Insider transaction Jul 18, 2025 Jun 18, 2025
4 Insider transaction Jul 18, 2025 Jun 18, 2025
4 Insider transaction Jul 18, 2025 Jun 18, 2025
4 Insider transaction Jul 18, 2025 Jun 18, 2025
8-K Current report
Other events
Jul 17, 2025 Jul 17, 2025
8-K Current report
Officer or director change
Jul 11, 2025 Jul 7, 2025
4 Insider transaction Jul 8, 2025 Jul 3, 2025
144 Notice of proposed sale Jul 3, 2025 —
8-K Current report
Shareholder vote results
Jun 18, 2025 Jun 18, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 5, 2025 —
8-K Current report
Regulation FD disclosure
May 27, 2025 May 27, 2025
4 Insider transaction May 22, 2025 May 20, 2025
4 Insider transaction May 22, 2025 May 20, 2025
4 Insider transaction May 22, 2025 May 20, 2025
4 Insider transaction May 22, 2025 May 20, 2025
4 Insider transaction May 22, 2025 May 20, 2025
4 Insider transaction May 20, 2025 May 16, 2025
4 Insider transaction May 20, 2025 May 16, 2025
4 Insider transaction May 20, 2025 May 16, 2025
4 Insider transaction May 20, 2025 May 16, 2025
4 Insider transaction May 20, 2025 May 16, 2025
144 Notice of proposed sale May 20, 2025 —
144 Notice of proposed sale May 20, 2025 —
144 Notice of proposed sale May 20, 2025 —
144 Notice of proposed sale May 20, 2025 —
144 Notice of proposed sale May 20, 2025 —
144 Notice of proposed sale May 16, 2025 —
144 Notice of proposed sale May 16, 2025 —
144 Notice of proposed sale May 16, 2025 —
144 Notice of proposed sale May 16, 2025 —
144 Notice of proposed sale May 16, 2025 —
8-K Current report
Regulation FD disclosure, Other events
May 15, 2025 May 15, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 7, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 7, 2025 —
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 30, 2025 —
DEF 14A Proxy statement Apr 30, 2025 Jun 18, 2025
8-K Current report
Officer or director change
Apr 29, 2025 Apr 26, 2025
4 Insider transaction Apr 24, 2025 Apr 22, 2025
4 Insider transaction Apr 24, 2025 Mar 5, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RCKT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1281895
Former names
INOTEK PHARMACEUTICALS CORP (until Dec 22, 2017)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.